Últimos Drogas artículos sobre cumplimiento normativo
Aprenda a navegar por el proceso de NDA 505B1 de la FDA, desde los requisitos de datos hasta los plazos de aprobación, el etiquetado y el cumplimiento. Evite retrasos con la orientación de expertos.
Read More
Aprenda a aprovechar la vía de NDA 505B2 para obtener una aprobación más rápida de la FDA. Utilice los datos existentes, reduzca los costes y obtenga exclusividad para productos farmacéuticos diferenciados.
Read More
Comprende las tarifas de usuario de GDUFA, las reglas de inspección y los consejos de cumplimiento para fabricantes de medicamentos genéricos y CMO. Evite retrasos y asegure un acceso más rápido al mercado estadounidense.
Read More
Una guía completa de OMUFA: Descubra cómo los fabricantes de medicamentos OTC pueden gestionar las tarifas de las instalaciones de la FDA, las OMOR, las exenciones y cumplir con el marco de la Ley CARES.
Read More
Aprenda a preparar presentaciones de eCTD para la FDA y los mercados globales. Póngase al día con la versión 4.0, consejos sobre el ciclo de vida y mejores prácticas para el éxito del cumplimiento.
Read More
Drogas Regulations FAQ
For Drug Establishments, who must register?
Domestic or foreign owners or operators of establishments that manufacture, prepare, propagate, compound, or process a drug or drugs and are not considered exempt must register their facility with FDA, according to the Code of Federal Regulations. In general, exemptions include pharmacies, professional licensed practitioners, researchers, teachers, analysts, and distributors.
What information is required for drug establishment registration?
Information you must submit as part of your FDA facility registration with your Structured Product Labeling (SPL) file includes:
- Company Name and full address of each establishment
- Name, address, phone number, and email address of official contact
- Type of operation(s) performed at each establishment
- DUNS number
- Facility Establishment Identifier (when assigned)
Non. U.S. establishments must also include:
- Name designated U.S. Agent
- Name of each importer known to the establishmentName of each agent, broker, or other entity, other than a carrier used to facilitate the import of their drug into the U.S.
- Include DUNS number, phone number and email address for each entry.
See Title 21 of the Code of Federal Regulations for a complete list.
Who must provide drug listings?
All drug establishments that are not considered exempt and must register with FDA must also submit initial listing information for all drugs in commercial distribution at the time of their original FDA facility registration, according to the Code of Federal Regulations.
In general, exemptions include pharmacies, professional licensed practitioners, researchers, teachers, analysts, and distributors.
What information is submitted for a drug listing?
Information you must submit as part of your FDA drug listing includes:
- Name of establishment(s) manufacturing or processing the listed drug and the type of operation(s) performed
- DEA schedule
- Route(s) of administration
- Dosage Form
- Ingredients (active with strength amounts and inactive)
- Marketing information (e.g., category, start/stop date)
- Information related to the application (e.g., type and year of approval) or OTC monograph citation number
- Package size and type
- NDC Product Code for a source drug repacked or relabeled
- Unique Ingredient Identifiers (UNII) and other code sets
- Distinctive Characteristics of certain listed drugs
- Labeling artwork
- National Drug Code (NDC) number
What is a master file?
A Master File is a secure, confidential submission of proprietary product data to a regulatory agency, such as the U.S. Food and Drug Administration (FDA), or the National Medical Products Association (NMPA) in China.